Clinical Trials Directory

Trials / Conditions / Multi-drug Resistant Tuberculosis

Multi-drug Resistant Tuberculosis

21 registered clinical trials studyying Multi-drug Resistant Tuberculosis — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingMolecular Epidemiology, Strains Genotyping of Multi-drug Resistant Tuberculosis Circulating in Central Africa
NCT07017803
Centre de Recherche Médicale de Lambaréné—
RecruitingAn Adaptive Randomized Controlled Trial
NCT05633056
Columbia UniversityN/A
CompletedA Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults
NCT05526911
Global Alliance for TB Drug DevelopmentPhase 1
CompletedEconomic Evaluation of New MDR TB Regimens
NCT04207112
Medecins Sans Frontieres, NetherlandsPhase 2 / Phase 3
UnknownNew Genomic Techniques and Management of Multidrug-resistant Tuberculosis
NCT04397536
Assistance Publique - Hôpitaux de Paris—
CompletedEvaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults
NCT04493671
Global Alliance for TB Drug DevelopmentPhase 1
UnknownPharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis
NCT03827811
University of Cape Town—
CompletedCase Control Study of Vitamin D Status and Adult Multidrug-resistant Pulmonary Tuberculosis in Maharashtra, In
NCT04342598
Harvard School of Public Health (HSPH)—
CompletedSingle-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Form
NCT04309656
Global Alliance for TB Drug DevelopmentPhase 1
CompletedBuilding Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short
NCT04062201
Wits Health Consortium (Pty) LtdPhase 3
UnknownPRACTECAL-PKPD Sub Study
NCT04081077
Medecins Sans Frontieres, NetherlandsPhase 2 / Phase 3
CompletedThe Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB
NCT03830671
Beijing Chest HospitalPhase 4
UnknownClinical Study on Adoptive Treatment of MDR-TB With Allogeneic γδT Cells
NCT03575299
Zhinan Yin, Ph.D.Phase 1
CompletedPost Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With M
NCT03470233
Korea Otsuka Pharmaceutical Co., Ltd.—
CompletedPK of Levofloxacin in MDR-TB Patients
NCT03000517
University Medical Center Groningen—
CompletedTreatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug Resistance
NCT03057756
Centre de Recherche Médicale de Lambaréné—
WithdrawnA Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Res
NCT01600963
Janssen Infectious Diseases BVBAPhase 3
CompletedEvaluation of PCR Using DNA Extract From Slides and Filter Paper for the Detection of Tuberculosis and MDR-tub
NCT03137875
Epicentre—
CompletedClinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort
NCT03822156
University of Ulsan—
CompletedTBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB
NCT00664313
Centers for Disease Control and PreventionPhase 1 / Phase 2
CompletedMetronidazole for Pulmonary Tuberculosis (South Korea)
NCT00425113
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2